Novocure to Evaluate Tumor Treating Fields Therapy With VS-7375
Novocure announced a clinical trial collaboration and supply agreement to evaluate its Tumor Treating Fields therapy with VS-7375 for pancreatic cancer.
Related stories
Proto Labs Shares Fall 7.6% After Q3 Results and Q4 Guidance
Proto Labs shares were down 7.6% in early Thursday trading. The headline reports higher Q3 adjusted earnings and revenue and that Q4 guidance was set.
M impact | EQUITY | Oct 29, 2026, 01:57 PM UTC
Bank of Jordan Q3 Profit Attributable to Shareholders Is 9.8 Million Dinars
M impact | EQUITY | Oct 29, 2026, 01:57 PM UTC
Alamos Gold Q3 2026 Earnings Call Begins
Alamos Gold's quarterly earnings call has begun.
M impact | EQUITY | Oct 29, 2026, 01:57 PM UTC
NWPX Infrastructure Q3 2026 Earnings Call Begins
NWPX Infrastructure's Q3 2026 earnings call has begun.
M impact | EQUITY | Oct 29, 2026, 01:57 PM UTC
Quanta Services Rises on Optimistic Outlook and Q3 Results
Quanta Services shares rose after the company reported third-quarter results above expectations and an optimistic outlook.
M impact | EQUITY | Oct 29, 2026, 01:57 PM UTC
Jiangxi Zhengbang Tech Reports Q3 Net Loss of 353.8 Million Yuan
Jiangxi Zhengbang Tech reported a net loss of 353.8 million yuan for the third quarter.
M impact | EQUITY | Oct 29, 2026, 01:56 PM UTC